A prospective, comparison trial of Abobotulinum Toxin a (Dysport) & Onabotulinum Toxin a (Botox) in patients with spinal cord injury (SCI).

Trial Profile

A prospective, comparison trial of Abobotulinum Toxin a (Dysport) & Onabotulinum Toxin a (Botox) in patients with spinal cord injury (SCI).

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 16 Dec 2015

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Neurogenic bladder; Spinal cord injuries
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Dec 2015 New trial record
    • 24 Oct 2014 Preliminary results presented at the 44th Annual Meeting of the International Continence Society
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top